Amedisys, Inc. (NASDAQ:AMED) Stock Holdings Trimmed by Bridgewater Associates LP

Bridgewater Associates LP lowered its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 52.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,824 shares of the health services provider’s stock after selling 14,189 shares during the period. Bridgewater Associates LP’s holdings in Amedisys were worth $1,238,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Citigroup Inc. raised its stake in Amedisys by 7.2% during the 3rd quarter. Citigroup Inc. now owns 192,768 shares of the health services provider’s stock valued at $18,604,000 after acquiring an additional 12,911 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Amedisys by 2.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock valued at $33,400,000 after purchasing an additional 9,004 shares during the period. Amara Financial LLC. acquired a new position in shares of Amedisys during the 3rd quarter valued at $526,000. KBC Group NV acquired a new position in shares of Amedisys during the 3rd quarter valued at $63,000. Finally, State of New Jersey Common Pension Fund D increased its position in shares of Amedisys by 1.7% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 20,357 shares of the health services provider’s stock valued at $1,965,000 after purchasing an additional 339 shares during the period. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Up 0.2 %

Shares of AMED stock opened at $91.41 on Monday. Amedisys, Inc. has a 1 year low of $88.81 and a 1 year high of $98.95. The stock has a market cap of $2.99 billion, a PE ratio of 36.27, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. The business’s fifty day moving average is $94.74 and its 200-day moving average is $95.62. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same quarter last year, the business posted $0.98 earnings per share. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. Equities analysts expect that Amedisys, Inc. will post 4.55 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.